{"id":"forsteo","safety":{"commonSideEffects":[{"rate":"~10-15%","effect":"Injection site reactions (erythema, pain)"},{"rate":"~8%","effect":"Nausea"},{"rate":"~5-7%","effect":"Dizziness"},{"rate":"~5%","effect":"Headache"},{"rate":"~3-5%","effect":"Leg cramps"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Teriparatide mimics the action of endogenous parathyroid hormone, which promotes bone anabolism when administered intermittently. It increases osteoblast activity and bone turnover, leading to net gains in bone mineral density. This mechanism differs from antiresorptive agents and makes it particularly effective for severe osteoporosis with high fracture risk.","oneSentence":"Forsteo (teriparatide) is a recombinant human parathyroid hormone analog that stimulates bone formation by activating PTH1 receptors on osteoblasts.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:30:14.672Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Osteoporosis in postmenopausal women"},{"name":"Osteoporosis in men at high risk of fracture"},{"name":"Glucocorticoid-induced osteoporosis"}]},"trialDetails":[{"nctId":"NCT07497503","phase":"PHASE1","title":"A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants","status":"NOT_YET_RECRUITING","sponsor":"Syneos Health","startDate":"2026-04-10","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT05965167","phase":"PHASE1","title":"Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo","status":"COMPLETED","sponsor":"Entera Bio Ltd.","startDate":"2023-05-11","conditions":"Hypoparathyroidism, Osteoporosis, Fractures, Bone","enrollment":45},{"nctId":"NCT05866029","phase":"NA","title":"Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-05-26","conditions":"Osteoporotic Fractures","enrollment":2478},{"nctId":"NCT01225055","phase":"PHASE2","title":"Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury","status":"COMPLETED","sponsor":"Thomas J. Schnitzer","startDate":"2010-10","conditions":"Spinal Cord Injury, Bone Loss, Osteoporosis","enrollment":60},{"nctId":"NCT03232476","phase":"PHASE4","title":"Effect of Mechanical Loading With PTH on Cortical Bone","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2017-07","conditions":"Osteoporosis, Postmenopausal","enrollment":""},{"nctId":"NCT07242612","phase":"NA","title":"Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-10-01","conditions":"Osteoporosis, Osteoporosis, Postmenopausal","enrollment":40},{"nctId":"NCT03735537","phase":"PHASE4","title":"Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2016-11-01","conditions":"Osteogenesis Imperfecta","enrollment":350},{"nctId":"NCT03994172","phase":"PHASE4","title":"Novel Combination Therapy for Osteoporosis in Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-07-01","conditions":"Male Osteoporosis","enrollment":40},{"nctId":"NCT04669782","phase":"NA","title":"Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging","status":"TERMINATED","sponsor":"University of Milano Bicocca","startDate":"2020-11-24","conditions":"Bone Metabolism Disorder, Aging Disorder, Osteoporosis","enrollment":99},{"nctId":"NCT06644040","phase":"PHASE1","title":"A Study of TeriQ Patch in Healthy Adult Female Participants","status":"COMPLETED","sponsor":"QuadMedicine","startDate":"2024-10-25","conditions":"Osteoporosis","enrollment":24},{"nctId":"NCT07028320","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk","status":"COMPLETED","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2021-12-03","conditions":"Postmenopausal Women With Osteoporosis","enrollment":493},{"nctId":"NCT06951776","phase":"NA","title":"Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-05-01","conditions":"Circadian Rhythm Disorders, Osteoporosis","enrollment":28},{"nctId":"NCT06164795","phase":"","title":"Sequential Therapies After Osteoanabolic Treatment","status":"RECRUITING","sponsor":"424 General Military Hospital","startDate":"2023-11-25","conditions":"Osteoporosis, Postmenopausal","enrollment":150},{"nctId":"NCT05151484","phase":"PHASE4","title":"Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover","status":"RECRUITING","sponsor":"Madhumathi Rao","startDate":"2022-03-21","conditions":"Age-Related Osteoporosis","enrollment":60},{"nctId":"NCT06264609","phase":"PHASE4","title":"Precision Medicine Approach for Osteoporosis - Follow Up Study","status":"ENROLLING_BY_INVITATION","sponsor":"Paul F Netzel","startDate":"2024-02-01","conditions":"Osteoporosis","enrollment":40},{"nctId":"NCT06898060","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-06","conditions":"Postmenopausal Women With Osteoporosis","enrollment":282},{"nctId":"NCT06558188","phase":"PHASE4","title":"Combined Anabolic Therapy","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-02-03","conditions":"Osteoporosis, Postmenopausal, Osteoporosis","enrollment":50},{"nctId":"NCT06842758","phase":"","title":"Relationship Between Thoracic Hyperkyphosis and Fall Risk in Women with Fragility Vertebral Fractures","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Palermo","startDate":"2023-05-01","conditions":"Osteoporosis, Hyperkyphosis, Vertebral Body Fracture","enrollment":40},{"nctId":"NCT03133195","phase":"PHASE3","title":"The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA","status":"COMPLETED","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2017-05-17","conditions":"Unstable Intertrochanteric Fracture, Pertrochanteric Fracture of Femur, Closed","enrollment":50},{"nctId":"NCT03770338","phase":"NA","title":"Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2019-03-01","conditions":"Osteoporosis, Fusion of Spine, Lumbar Region","enrollment":192},{"nctId":"NCT01155245","phase":"","title":"Teriparatide (PTH) and Bone Strength in Postmenopausal Women","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2008-06","conditions":"Osteoporosis","enrollment":60},{"nctId":"NCT04522622","phase":"PHASE4","title":"Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Ditte Hansen","startDate":"2021-12-15","conditions":"Adynamic Bone Disease, Chronic Kidney Diseases, Cardiac Disease","enrollment":48},{"nctId":"NCT04974723","phase":"","title":"Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women","status":"COMPLETED","sponsor":"Radius Health, Inc.","startDate":"2021-07-01","conditions":"Osteoporosis, Postmenopausal","enrollment":22054},{"nctId":"NCT02932501","phase":"","title":"Medication-related Osteonecrosis of the Jaw (MRONJ) Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"AO Clinical Investigation and Publishing Documentation","startDate":"2017-08-14","conditions":"Medication-related Osteonecrosis of the Jaw, Bisphosphonate-Associated Osteonecrosis of the Jaw","enrollment":518},{"nctId":"NCT06303284","phase":"PHASE1, PHASE2","title":"Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-01-01","conditions":"Ankle Fractures","enrollment":80},{"nctId":"NCT06061354","phase":"PHASE4","title":"Teriparatide on Maxillary Sinus Floor Osseointegration","status":"UNKNOWN","sponsor":"Universidad de Valparaiso","startDate":"2023-08-23","conditions":"Bone Regeneration","enrollment":42},{"nctId":"NCT04026256","phase":"PHASE4","title":"Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-09-02","conditions":"Postmenopausal Osteoporosis","enrollment":37},{"nctId":"NCT04879420","phase":"","title":"Replication of the VERO Osteoporosis Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-10-29","conditions":"Osteoporosis","enrollment":12757},{"nctId":"NCT01155232","phase":"","title":"Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2004-11","conditions":"Osteoporosis","enrollment":100},{"nctId":"NCT01896011","phase":"PHASE3","title":"Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2013-07","conditions":"Non Displaced Atypical Femoral Fractures","enrollment":34},{"nctId":"NCT03072147","phase":"PHASE2","title":"Teriparatide as a Chondroregenerative Therapy in OA","status":"COMPLETED","sponsor":"Christopher Ritchlin","startDate":"2017-05-01","conditions":"Knee Osteoarthritis, Cartilage Degeneration","enrollment":76},{"nctId":"NCT02025179","phase":"PHASE2","title":"12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2013-01","conditions":"Spinal Cord Injury, Bone Loss, Osteoporosis","enrollment":25},{"nctId":"NCT05366621","phase":"","title":"Post-fracture Medication and Mortality","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-11-01","conditions":"Osteoporosis, Osteoporosis Fracture, Drug Therapy","enrollment":216155},{"nctId":"NCT02195895","phase":"PHASE2","title":"Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2014-04","conditions":"Spinal Cord Injury, Bone Loss, Osteoporosis","enrollment":17},{"nctId":"NCT04589819","phase":"PHASE4","title":"Fracture Recovery for Returning to Duty (Teriparatide STRONG)","status":"ENROLLING_BY_INVITATION","sponsor":"University of South Carolina","startDate":"2022-12-08","conditions":"Stress Fracture of Tibia or Fibula","enrollment":183},{"nctId":"NCT03472846","phase":"PHASE4","title":"MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2017-03-01","conditions":"Postmenopausal Osteoporosis, Diabetes Type 2","enrollment":26},{"nctId":"NCT02440581","phase":"NA","title":"Renal Osteodystrophy: An Individual Management Approach","status":"COMPLETED","sponsor":"Hartmut Malluche, MD","startDate":"2015-07-01","conditions":"Kidney Failure, Chronic","enrollment":141},{"nctId":"NCT02049866","phase":"PHASE2","title":"Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP","status":"COMPLETED","sponsor":"Elizabeth Shane","startDate":"2014-11-19","conditions":"Adult Idiopathic Generalized Osteoporosis","enrollment":33},{"nctId":"NCT01796301","phase":"PHASE3","title":"An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women","status":"COMPLETED","sponsor":"Amgen","startDate":"2013-01-31","conditions":"Postmenopausal Osteoporosis","enrollment":436},{"nctId":"NCT04750460","phase":"PHASE3","title":"Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).","status":"COMPLETED","sponsor":"Saint Petersburg State University, Russia","startDate":"2021-03-01","conditions":"Secondary Hyperparathyroidism, Chronic Kidney Disease-Mineral and Bone Disorder, Dialysis","enrollment":20},{"nctId":"NCT05164614","phase":"PHASE1","title":"Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule","status":"COMPLETED","sponsor":"RANI Therapeutics","startDate":"2022-02-21","conditions":"Healthy Volunteers","enrollment":50},{"nctId":"NCT00896532","phase":"PHASE2","title":"Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-06-03","conditions":"Low Bone Mineral Density, Postmenopausal Osteoporosis","enrollment":419},{"nctId":"NCT02972424","phase":"PHASE2","title":"PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-05-01","conditions":"Osteoporotic Fractures","enrollment":35},{"nctId":"NCT05369013","phase":"","title":"Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.","status":"UNKNOWN","sponsor":"STADA, Spain","startDate":"2021-06-15","conditions":"Osteoporosis","enrollment":188},{"nctId":"NCT00754442","phase":"NA","title":"Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2007-02","conditions":"Secondary Hyperparathyroidism","enrollment":20},{"nctId":"NCT02536898","phase":"NA","title":"Norwegian Capture the Fracture Initiative","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2015-05","conditions":"Hip Fracture, Vertebral Fracture, Other Low-trauma Fracture","enrollment":94260},{"nctId":"NCT03702140","phase":"PHASE2","title":"Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy","status":"UNKNOWN","sponsor":"Shinshu University","startDate":"2018-10-09","conditions":"Osteoporosis","enrollment":90},{"nctId":"NCT05018637","phase":"PHASE2","title":"Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture","status":"UNKNOWN","sponsor":"Inbo Han","startDate":"2020-09-01","conditions":"Vertebral Compression Fracture, Osteoporotic Fractures","enrollment":30},{"nctId":"NCT04921124","phase":"PHASE3","title":"Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes","status":"COMPLETED","sponsor":"Norfolk and Norwich University Hospitals NHS Foundation Trust","startDate":"2021-05-24","conditions":"Stress Fracture","enrollment":30},{"nctId":"NCT02023411","phase":"PHASE2","title":"Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2014-01","conditions":"Diabetic Neuropathic Arthropathy","enrollment":20},{"nctId":"NCT02824718","phase":"PHASE2","title":"Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-06","conditions":"Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment","enrollment":16},{"nctId":"NCT04003467","phase":"PHASE2","title":"A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass","status":"COMPLETED","sponsor":"Entera Bio Ltd.","startDate":"2019-06-30","conditions":"Osteoporosis","enrollment":161},{"nctId":"NCT01679080","phase":"PHASE2","title":"The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2012-11","conditions":"Osteogenesis Imperfecta","enrollment":9},{"nctId":"NCT01292252","phase":"PHASE4","title":"Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion","status":"COMPLETED","sponsor":"Shane Burch","startDate":"2011-08","conditions":"Lumbar Spondylosis, Lumbar Spondylolisthesis, Adult Degenerative Lumbar Scoliosis","enrollment":36},{"nctId":"NCT04747392","phase":"PHASE1","title":"Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults","status":"COMPLETED","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2020-08-19","conditions":"Postmenopausal Osteoporosis","enrollment":64},{"nctId":"NCT02176382","phase":"PHASE4","title":"Denosumab and Teriparatide Study (DATA-HD and DATA-EX)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2014-08","conditions":"Postmenopausal Osteoporosis","enrollment":76},{"nctId":"NCT04206618","phase":"","title":"Circulating Myokine Levels and Bone Metabolism","status":"COMPLETED","sponsor":"424 General Military Hospital","startDate":"2019-06-01","conditions":"Osteoporosis, Postmenopausal","enrollment":220},{"nctId":"NCT02252679","phase":"","title":"Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium Disorders","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2014-10","conditions":"Bone Diseases, Osteomalacia, Osteoporosis","enrollment":54},{"nctId":"NCT04196855","phase":"PHASE3","title":"Study of Teriparatide in Stress Fracture Healing","status":"UNKNOWN","sponsor":"University of East Anglia","startDate":"2019-12-23","conditions":"Stress Fracture, Parathyroid Hormone","enrollment":136},{"nctId":"NCT02156960","phase":"PHASE4","title":"Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients","status":"UNKNOWN","sponsor":"Shinshu University","startDate":"2014-05","conditions":"Osteoporosis","enrollment":100},{"nctId":"NCT02563353","phase":"NA","title":"PTH and Vibration in OSteoporosis Study","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2015-11","conditions":"Osteoporosis","enrollment":35},{"nctId":"NCT01656629","phase":"NA","title":"Stem Cell Recruitment in Osteoporosis Therapy","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2012-08","conditions":"Low Bone Density","enrollment":55},{"nctId":"NCT04473989","phase":"PHASE2","title":"Weekly Use of Teriparatide to Accelerate Healing of Distal Radius Fracture","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-06-01","conditions":"Colles' Fracture","enrollment":80},{"nctId":"NCT04241211","phase":"PHASE4","title":"Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-01-01","conditions":"Spine Deformity","enrollment":64},{"nctId":"NCT01440803","phase":"PHASE2","title":"Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women","status":"COMPLETED","sponsor":"Elizabeth Shane","startDate":"2012-08-02","conditions":"Adult Idiopathic Generalized Osteoporosis","enrollment":41},{"nctId":"NCT03217513","phase":"","title":"Knee Osteoarthritis Outcome Measures in Arthritic Patients With Osteoporosis","status":"WITHDRAWN","sponsor":"Edward Fox","startDate":"2020-01-01","conditions":"Osteoporosis, Knee Osteoarthritis","enrollment":""},{"nctId":"NCT04126941","phase":"","title":"Monocentric Study on the Use of Teriparatide in Children With hypoparathyroïdism","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2019-06-01","conditions":"Hypoparathyroidism","enrollment":9},{"nctId":"NCT00887354","phase":"PHASE4","title":"A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-04","conditions":"Osteoporosis","enrollment":224},{"nctId":"NCT01709110","phase":"PHASE4","title":"VERtebral Fracture Treatment Comparisons in Osteoporotic Women","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-10","conditions":"Postmenopausal Osteoporosis","enrollment":1366},{"nctId":"NCT00131469","phase":"PHASE4","title":"Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2005-06","conditions":"Osteogenesis Imperfecta","enrollment":79},{"nctId":"NCT02090244","phase":"PHASE4","title":"Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?","status":"COMPLETED","sponsor":"University Hospital, Linkoeping","startDate":"2012-08","conditions":"Spinal Stenosis","enrollment":34},{"nctId":"NCT02239523","phase":"NA","title":"Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit Analysis","status":"COMPLETED","sponsor":"Shaare Zedek Medical Center","startDate":"2017-02-21","conditions":"Osteoporotic Fracture","enrollment":200},{"nctId":"NCT02472782","phase":"","title":"Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication","status":"COMPLETED","sponsor":"251 Hellenic Air Force & VA General Hospital","startDate":"2015-05","conditions":"Osteoporosis, Postmenopausal, Osteoporosis, Steroid Induced","enrollment":851},{"nctId":"NCT03720886","phase":"PHASE1, PHASE2","title":"G56W1 in Women With Postmenopausal Osteoporosis","status":"UNKNOWN","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2018-10-01","conditions":"Postmenopausal Osteoporosis","enrollment":148},{"nctId":"NCT03692143","phase":"","title":"Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2017-01-01","conditions":"Osteoporosis, Postmenopausal, Vertebral Fracture, Quality of Life","enrollment":90},{"nctId":"NCT00489918","phase":"PHASE2","title":"Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Zosano Pharma Corporation","startDate":"2007-06","conditions":"Osteoporosis","enrollment":165},{"nctId":"NCT00697463","phase":"PHASE2, PHASE3","title":"Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women","status":"COMPLETED","sponsor":"Columbia University","startDate":"2008-08-20","conditions":"Menopause, Fracture, Osteoporosis","enrollment":22},{"nctId":"NCT00926380","phase":"PHASE2","title":"Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-06","conditions":"Osteoporosis","enrollment":94},{"nctId":"NCT03002428","phase":"PHASE3","title":"A Comparison of PF708 and Forteo in Osteoporosis Patients","status":"COMPLETED","sponsor":"Pfenex, Inc","startDate":"2016-12","conditions":"Osteoporosis","enrollment":181},{"nctId":"NCT02637180","phase":"","title":"Secondary Prevention of Osteoporotic Fractures: a Multiple Center Fracture Liaison Service in Greece","status":"COMPLETED","sponsor":"Hellenic Society for the Study of Bone Metabolism","startDate":"2015-04","conditions":"Osteoporosis","enrollment":397},{"nctId":"NCT01279187","phase":"PHASE2","title":"The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone","status":"TERMINATED","sponsor":"University of Michigan","startDate":"2011-02","conditions":"Implant","enrollment":27},{"nctId":"NCT02571140","phase":"PHASE1","title":"A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects","status":"COMPLETED","sponsor":"Entera Bio Ltd.","startDate":"2013-10","conditions":"Drug Safety and Bioavailability","enrollment":30},{"nctId":"NCT01705587","phase":"PHASE4","title":"Fracture (FX) Improvement With Teriparatide: FiX-IT Study","status":"COMPLETED","sponsor":"Susan L. Greenspan","startDate":"2012-12","conditions":"Osteoporosis, Atypical Femoral Fracture","enrollment":13},{"nctId":"NCT00471237","phase":"PHASE2","title":"A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2007-05-14","conditions":"Osteoporosis","enrollment":564},{"nctId":"NCT00542425","phase":"PHASE2","title":"Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Radius Health, Inc.","startDate":"2007-04","conditions":"Osteoporosis","enrollment":222},{"nctId":"NCT02130973","phase":"PHASE4","title":"The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab","status":"UNKNOWN","sponsor":"Health Research, Inc.","startDate":"2013-08","conditions":"Osteoporosis","enrollment":60},{"nctId":"NCT00668941","phase":"PHASE2","title":"Cyclic Versus Daily Teriparatide on Bone Mass","status":"UNKNOWN","sponsor":"Helen Hayes Hospital","startDate":"2005-09","conditions":"Osteoporosis","enrollment":140},{"nctId":"NCT01153425","phase":"PHASE4","title":"µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2008-07","conditions":"Osteoporosis, Osteopenia","enrollment":33},{"nctId":"NCT00759772","phase":"PHASE2","title":"The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-09","conditions":"Anorexia Nervosa, Osteoporosis","enrollment":23},{"nctId":"NCT01293292","phase":"PHASE4","title":"Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2011-01","conditions":"Osteoporosis","enrollment":19},{"nctId":"NCT00361595","phase":"NA","title":"Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2006-08","conditions":"Osteoporosis","enrollment":35},{"nctId":"NCT01400516","phase":"PHASE4","title":"Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2011-08","conditions":"Rheumatoid Arthritis","enrollment":26},{"nctId":"NCT01750086","phase":"PHASE4","title":"Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2013-01","conditions":"Postmenopausal Osteoporosis","enrollment":27},{"nctId":"NCT01343004","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women","status":"COMPLETED","sponsor":"Radius Health, Inc.","startDate":"2011-04","conditions":"Osteoporosis, Postmenopausal Osteoporosis","enrollment":2463},{"nctId":"NCT01935479","phase":"PHASE1","title":"A Phase I Study of AK159 in Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Asahi Kasei Pharma Corporation","startDate":"2013-08","conditions":"Osteoporosis","enrollment":170},{"nctId":"NCT02304887","phase":"","title":"The Relationship Between the Residual Renal Function and Osteoporosis Treatment","status":"UNKNOWN","sponsor":"Toshihiko Kono","startDate":"2006-01","conditions":"Osteoporosis","enrollment":1000},{"nctId":"NCT01309399","phase":"NA","title":"Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur","status":"COMPLETED","sponsor":"Health Research, Inc.","startDate":"2010-08","conditions":"Osteoporosis","enrollment":40},{"nctId":"NCT02955056","phase":"PHASE4","title":"Ankle Fractures Treated With Teriparatide","status":"UNKNOWN","sponsor":"Nottingham University Hospitals NHS Trust","startDate":"2016-10","conditions":"Fracture, Ankle","enrollment":10},{"nctId":"NCT02166437","phase":"","title":"Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese","status":"UNKNOWN","sponsor":"Tomidahama Hospital","startDate":"2013-11","conditions":"Osteoporosis","enrollment":500},{"nctId":"NCT01956461","phase":"","title":"Effects of Teriparatide Therapy for Japanese","status":"UNKNOWN","sponsor":"Tomidahama Hospital","startDate":"2010-09","conditions":"Osteoporosis","enrollment":500}],"_emaApprovals":[],"_faersSignals":[{"count":494,"reaction":"FALL"},{"count":420,"reaction":"DEATH"},{"count":215,"reaction":"DIZZINESS"},{"count":188,"reaction":"NAUSEA"},{"count":158,"reaction":"PAIN IN EXTREMITY"},{"count":157,"reaction":"PAIN"},{"count":151,"reaction":"FATIGUE"},{"count":137,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":136,"reaction":"BACK PAIN"},{"count":124,"reaction":"FEMUR FRACTURE"}],"_approvalHistory":[],"publicationCount":41,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["teriparatide","Teriparatide hormone"],"phase":"marketed","status":"active","brandName":"FORSTEO","genericName":"FORSTEO","companyName":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","companyId":"shenzhen-salubris-pharmaceuticals-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Forsteo (teriparatide) is a recombinant human parathyroid hormone analog that stimulates bone formation by activating PTH1 receptors on osteoblasts. Used for Osteoporosis in postmenopausal women, Osteoporosis in men at high risk of fracture, Glucocorticoid-induced osteoporosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}